Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Former Cleveland Fed President: fewer rate cuts coming next year

Former Cleveland Fed President: fewer rate cuts coming next year

Bitget2024/11/12 15:37

Former Cleveland Fed President Mester said the Fed's rate of interest rate cuts next year will be affected by fiscal policy, the number of times may not be as many as assumed or expected in September. Mester noted that the Fed's outlook will change with the fiscal plans of the incoming Republican administration, and that the market may have correctly predicted that there will be fewer than the four rate cuts that were previously expected. ‘Next year, the pace of rate cuts will be influenced by fiscal policy,’ said economists polled by Reuters, who also expect a 25 basis point cut at the December 2024 meeting. That would bring the federal funds rate down to 3 per cent to 3.25 per cent by the end of 2025, slightly below the Fed's median ‘dot plot’ forecast.

1
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "chip dollar" is on the rise! Deutsche Bank: Asia's chip trade surplus flows into US stocks, becoming a new pillar for the dollar

Deutsche Bank believes that the continuously expanding chip trade surplus in Asia is becoming a supporting force for the US dollar, as related profits are increasingly being reinvested into the US stock market.

智通财经•2026/11/16 23:03
The "chip dollar" is on the rise! Deutsche Bank: Asia's chip trade surplus flows into US stocks, becoming a new pillar for the dollar

Roche's (RHHBY.US) new breast cancer drug Wilserdly approved by FDA: Analysts predict peak annual sales could reach up to $14.5 billion

Roche's (RHHBY.US) new oral breast cancer drug has been approved by U.S. regulators, paving the way for this medication, which the pharmaceutical company hopes will transform the treatment of the disease.

智通财经•2026/11/16 22:53